Chapter 1.       DRUG OF ABUSE (DOA) TESTING MARKET  – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2.       DRUG OF ABUSE (DOA) TESTING MARKET  – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

 2.3.1. Impact during 2023 - 2030

  2.3.2. Impact on Supply – Demand

Chapter 3.       DRUG OF ABUSE (DOA) TESTING MARKET  – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4.      DRUG OF ABUSE (DOA) TESTING MARKET  - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatorycenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5.     DRUG OF ABUSE (DOA) TESTING MARKET   - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6.   DRUG OF ABUSE (DOA) TESTING MARKET – By Drug Type

6.1. Alcohol

6.2. Cannabis/Marijuana

6.3. Cocaine

6.4. Opioids

6.5. Amphetamine & Methamphetamine

6.6. LSD

6.7. Others

Chapter 7.       DRUG OF ABUSE (DOA) TESTING MARKET  – By Region

7.1. North America

7.2. Europe

7.3. Asia-P2acific

7.4. Latin America

7.5. The Middle East

7.6. Africa

Chapter 8.       DRUG OF ABUSE (DOA) TESTING MARKET  – By Companies

8.1. Companies 1

8.2. Companies 2

8.3. Companies 3 

8.4. Companies 4

8.5. Companies 5

8.6. Companies 6

8.7. Companies 7

8.8. Companies 8

8.9. Companies 9

8.10. Companies 10